Showing 71,281 - 71,300 results of 112,774 for search '(( 50 ((mean decrease) OR (a decrease)) ) OR ( 5 ((mean decrease) OR (a decrease)) ))', query time: 1.35s Refine Results
  1. 71281

    Data_Sheet_1_Trends in the global burden of vision loss among the older adults from 1990 to 2019.DOCX by Jiayang Yin (9273813)

    Published 2024
    “…YLDs associated with vision loss saw a significant decrease, moving from 1713.5 (95% UI: 1216.2–2339.7) to 1579.1 (95% UI: 1108.3–2168.9, AAPC: −0.12). …”
  2. 71282

    Data_Sheet_6_Trends in the global burden of vision loss among the older adults from 1990 to 2019.DOCX by Jiayang Yin (9273813)

    Published 2024
    “…YLDs associated with vision loss saw a significant decrease, moving from 1713.5 (95% UI: 1216.2–2339.7) to 1579.1 (95% UI: 1108.3–2168.9, AAPC: −0.12). …”
  3. 71283

    Supplementary file 1_Widespread declining in vegetation climate sensitivity across Central Asia.docx by Ping Jiang (243020)

    Published 2025
    “…Temporally, the VSI in Central Asia showed a clear declining trend, with the rate of decrease accelerating after 1995 from −0.274 to −0.476. …”
  4. 71284

    Image1_Comparison of perventricular and percutaneous ultrasound-guided device closure of perimembranous ventricular septal defects.tif by Liu Liu Huang (17339485)

    Published 2023
    “…</p>Results<p>Patients of the PCP and PVP groups had a median age of 4.9 years (IQR, 3.1–14.0) and 5.3 years (IQR, 3.4–13.1) respectively. …”
  5. 71285

    Multi-way sensitivity analysis on regional access to care and linkage to care with POC-CD4 compared to LAB-CD4. by Emily P. Hyle (512613)

    Published 2014
    “…<p>Projected decrease in 5-y mortality and ICERs with use of POC-CD4 compared to LAB-CD4 in four settings that represent a range of access to care (decreasing access to care from left to right) and with different probabilities of linkage with POC-CD4 (increasing up the vertical axis). …”
  6. 71286

    Effects of HDAC8 inhibition on MPNST cell cycle and apoptosis. by Gonzalo Lopez (22820)

    Published 2015
    “…<p><b>A.</b> PI staining/FACS analyses showing the effect of HDACis (PCI2 0.5μM/48h, PCI3/4 5μM/48h) on human and murine-derived MPNST cell cycle progression. …”
  7. 71287

    Table2_Comparison of perventricular and percutaneous ultrasound-guided device closure of perimembranous ventricular septal defects.docx by Liu Liu Huang (17339485)

    Published 2023
    “…</p>Results<p>Patients of the PCP and PVP groups had a median age of 4.9 years (IQR, 3.1–14.0) and 5.3 years (IQR, 3.4–13.1) respectively. …”
  8. 71288

    Table1_Comparison of perventricular and percutaneous ultrasound-guided device closure of perimembranous ventricular septal defects.docx by Liu Liu Huang (17339485)

    Published 2023
    “…</p>Results<p>Patients of the PCP and PVP groups had a median age of 4.9 years (IQR, 3.1–14.0) and 5.3 years (IQR, 3.4–13.1) respectively. …”
  9. 71289

    Data_Sheet_1.pdf by Xinyu Wang (341591)

    Published 2018
    “…The PNP degradation efficiency of a biocathode BES with 0.5 V (Bioc-0.5) reached 99.5 ± 0.8%, which was higher than the degradation efficiency of the BES with 0 V (Bioc-0) (62.4 ± 4.5%) and the OC-BES (59.2 ± 12.5%). …”
  10. 71290

    Redox status of rat cortical neurons. by Inmaculada Posadas (218859)

    Published 2013
    “…V stands for vehicle (DMSO 1‰)-treated cells. Data represent the mean ± SEM of 9 independent experiments. ***, p<i><</i>0.001 as compared to vehicle-treated cells (V); <sup>###</sup>, p<i><</i>0.001 compared to AAP 2 mM (A2). …”
  11. 71291

    Table_7_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

    Published 2024
    “…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”
  12. 71292

    Table_8_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

    Published 2024
    “…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”
  13. 71293

    Table_3_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

    Published 2024
    “…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”
  14. 71294

    Table_12_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

    Published 2024
    “…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”
  15. 71295

    Table_3_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

    Published 2024
    “…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”
  16. 71296

    Table_13_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

    Published 2022
    “…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”
  17. 71297

    Data_Sheet_1_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

    Published 2022
    “…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”
  18. 71298

    Table_13_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

    Published 2024
    “…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”
  19. 71299

    Data_Sheet_2_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.DOCX by Beatrice Vione (10734998)

    Published 2024
    “…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”
  20. 71300

    Table_7_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

    Published 2024
    “…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”